The company's Biomea that is the lead program, icovamenib, is the first in the category of menin inhibitors directed to the treatment of both type 1 and type 2 diabetes that holds the potential to ...

Google has shifted from a search engine to an answer engine, but its AI health answers can be misleading and even outright ...